Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia

Heart and Vessels

Volumn 31, Issue 6, 2016, Pages 990-995

  Hashimura, Hiromi ^a   Ishibashi Ueda, Hatsue ^a   Yonemoto, Yumiko ^a   Ohta Ogo, Keiko ^a   Matsuyama, Taka aki ^a   Ikeda, Yoshihiko ^a   Morita, Yoshiaki ^a   Yamada, Naoaki ^a   Yasui, Hiroki ^a   Naito, Hiroaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiac amyloidosis; Late gadolinium enhancement; Magnetic resonance imaging; Pathology

Indexed keywords

AMYLOID; BENCE JONES PROTEIN; BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; TROPONIN T; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AMYLOIDOSIS; ARTICLE; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CAUSE OF DEATH; CONTRAST ENHANCEMENT; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; JUGULAR VEIN; LEG EDEMA; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BIOPSY; SUBENDOCARDIAL FIBROSIS; URINALYSIS; AUTOPSY; CARDIOMYOPATHY; CHEMISTRY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; FATALITY; FIBROSIS; METABOLISM; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES;

AMYLOID; AMYLOIDOSIS; AUTOPSY; CARDIOMYOPATHIES; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FATAL OUTCOME; FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS;

EID: 84925432574     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-015-0658-0     Document Type: Article

References (20)

1. Burke A, Tavora F (2011) restrictive cardiomyopathy and cardiac amyloidosis. practical cardiovascular pathology. Lippincott Williams and Wilkis, Philadelphia, pp 184–194
2. Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD (2005) Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med 118:1287
3. Hosch W, Kristen AV, Libicher M, Dengler TJ, Aulmann S, Heye T (2008) Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings. Amyloid 15:196–204
4. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193
5. Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92:343–349
6. Kono AK, Yamada N, Higashi M, Kanzaki S, Hashimura H, Morita Y, Sakuma T, Noguchi T, Naito H, Sugimura K (2011) Dynamic late gadolinium enhancement simply quantified using myocardium to lumen signal ratio: normal range of ratio and diffuse abnormal enhancement of cardiac amyloidosis. J Magn Reson Imaging 34:50–55
7. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51:1022–1030
8. Smith RR, Hutchins GM (1979) Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 44:413–417
9. Yagishita A, Tanimoto S, Tanabe K, Isogawa A, Taniguchi M, Shiba T (2009) Cardiac amyloidosis presumptively diagnosed as cardiac syndrome X. Circ J 73:1349–1351
10. Morin J, Schreiber WE, Lee C (2013) Sudden death due to undiagnosed primary amyloidosis. J Forensic Sci 58(Suppl 1):S250–S252
11. Mueller PS, Edwards WD, Gertz MA (2000) Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 109:181–188
12. Tsai SB, Seldin DC, Wu H, O’Hara C, Ruberg FL, Sanchorawala V (2011) Myocardial infarction with “clean coronaries” caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid 18:160–164
13. Wittich CM, Neben-Wittich MA, Mueller PS, Gertz MA, Edwards WD (2007) Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis. Cardiovasc Pathol 16:75–78
14. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155–164
15. Minutoli F, Di Bella G, Mazzeo A, Donato R, Russo M, Scribano E, Baldari S (2013) Comparison between (99 m) Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 200:W256–W265
16. Di Bella G, Minutoli F, Mazzeo A, Vita G, Oreto G, Carerj S, Anfuso C, Russo M, Gaeta M (2010) MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 195:W394–W399
17. vanden Driesen RI, Slaughter RE, Strugnell WE (2006) MR findings in cardiac amyloidosis. AJR Am J Roentgenol 186:1682–1685
18. Migrino RQ, Harmann L, Christenson R, Hari P (2013) Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study. Heart Vessels. doi:10.1007/s00380-013-0419-x
19. Minutoli F, Di Bella G, Sindoni A, Vita G, Baldari S (2013) Effectiveness of skeletal scintigraphy in transthyretin-related amyloidosis. Int J Cardiol 168:4988–4989
20. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54